Skip to main content

Potassium

Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia

Bruce S. Spinowitz, Steven Fishbane, Pablo E. Pergola, Simon D. Roger, Edgar V. Lerma, Javed Butler, Stephan von Haehling, Scott H. Adler, June Zhao, Bhupinder Singh, Philip T. Lavin, Peter A. McCullough, Mikhail Kosiborod, David K. Packham
Clin J Am Soc Nephrol . 2019 Jun 7;14(6):798-809

Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors

Weir MR, Bakris GL, Bushinsky DA, Mayo MR, Garza D, Stasiv Y, Wittes J, Christ-Schmidt H, Berman L, Pitt B; OPAL-HK Investigators
N Engl J Med. 2015 Jan 15;372(3):211-21

Sodium zirconium cyclosilicate in hyperkalemia

Packham DK, Rasmussen HS, Lavin PT, El-Shahawy MA, Roger SD, Block G, Qunibi W, Pergola P, Singh B
N Engl J Med. 2015 Jan 15;372(3):222-31

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA
N Engl J Med. 2004 Aug 5;351(6):543-51
ukidneyisup